Rachael Natrajan

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 23

Top Venues

EMBO molecular medicine

British journal of cancer

The Journal of pathology

NPJ breast cancer

Institute of Cancer Research

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute of Cancer Research Jan 15 2012

United Kingdom

Team Leader :: Breast Cancer

Publications

John Alexander, Koen Schipper, Sarah Nash, Rachel Brough, Harriet Kemp, Jacopo Iacovacci, Clare M Isacke, Rachael Natrajan, Elinor J Sawyer, Christopher J Lord, Syed Haider
Pathway-based signatures predict patient outcome, chemotherapy benefit and synthetic lethal dependencies in invasive lobular breast cancer. British journal of cancer 130 (11) (2024)
John Alexander, Koen Schipper, Sarah Nash, Rachel Brough, Harriet Kemp, Jacopo Iacovacci, Clare M Isacke, Rachael Natrajan, Elinor J Sawyer, Christopher J Lord, Syed Haider
Pathway-based signatures predict patient outcome, chemotherapy benefit and synthetic lethal dependencies in invasive lobular breast cancer. British journal of cancer 130 (11) (2024)
Mohammed Inayatullah, Arun Mahesh, Arran K Turnbull, J Michael Dixon, Rachael Natrajan, Vijay K Tiwari
Basal-epithelial subpopulations underlie and predict chemotherapy resistance in triple-negative breast cancer. EMBO molecular medicine 16 (4) (2024)
Mohammed Inayatullah, Arun Mahesh, Arran K Turnbull, J Michael Dixon, Rachael Natrajan, Vijay K Tiwari
Basal-epithelial subpopulations underlie and predict chemotherapy resistance in triple-negative breast cancer. EMBO molecular medicine 16 (4) (2024)
Mohammed Inayatullah, Arun Mahesh, Arran K Turnbull, J Michael Dixon, Rachael Natrajan, Vijay K Tiwari
Basal-epithelial subpopulations underlie and predict chemotherapy resistance in triple-negative breast cancer. EMBO molecular medicine 16 (4) (2024)
John Alexander, Koen Schipper, Sarah Nash, Rachel Brough, Harriet Kemp, Jacopo Iacovacci, Clare M Isacke, Rachael Natrajan, Elinor J Sawyer, Christopher J Lord, Syed Haider
Pathway-based signatures predict patient outcome, chemotherapy benefit and synthetic lethal dependencies in invasive lobular breast cancer. British journal of cancer (2024)
Mohammed Inayatullah, Arun Mahesh, Arran K Turnbull, J Michael Dixon, Rachael Natrajan, Vijay K Tiwari
Basal-epithelial subpopulations underlie and predict chemotherapy resistance in triple-negative breast cancer. EMBO molecular medicine (2024)
Mohammed Inayatullah, Arun Mahesh, Arran K Turnbull, J Michael Dixon, Rachael Natrajan, Vijay K Tiwari
Basal-epithelial subpopulations underlie and predict chemotherapy resistance in triple-negative breast cancer. EMBO molecular medicine (2024)
John Alexander, Koen Schipper, Sarah Nash, Rachel Brough, Harriet Kemp, Jacopo Iacovacci, Clare M Isacke, Rachael Natrajan, Elinor J Sawyer, Christopher J Lord, Syed Haider
Pathway-based signatures predict patient outcome, chemotherapy benefit and synthetic lethal dependencies in invasive lobular breast cancer. British journal of cancer 130 (11) (2024)
Mohammed Inayatullah, Arun Mahesh, Arran K Turnbull, J Michael Dixon, Rachael Natrajan, Vijay K Tiwari
Basal-epithelial subpopulations underlie and predict chemotherapy resistance in triple-negative breast cancer. EMBO molecular medicine 16 (4) (2024)
Marcela Braga Mansur, Nandita M deSouza, Rachael Natrajan, Lisa M Abegglen, Joshua D Schiffman, Mel F Greaves
Evolutionary determinants of curability in cancer. Nature ecology & evolution (2023)
Philip Bland, Harry Saville, Patty T Wai, Lucinda Curnow, Gareth Muirhead, Jadwiga Nieminuszczy, Nivedita Ravindran, Marie Beatrix John, Somaieh Hedayat, Holly E Barker, James Wright, Lu Yu, Ioanna Mavrommati, Abigail Read, Barrie Peck, Mark Allen, Patrycja Gazinska, Helen N Pemberton, Aditi Gulati, Sarah Nash, Farzana Noor, Naomi Guppy, Ioannis Roxanis, Guy Pratt, Ceri E Oldreive, Tatjana Stankovic, Samantha Barlow, Helen Kalirai, Sarah E Coupland, Ronan Broderick, Samar Alsafadi, Alexandre Houy, Marc-Henri Stern, Stephen J Pettitt, Jyoti Sharma Choudhary, Syed Haider, Wojciech Niedzwiedz, Christopher J Lord, Rachael Natrajan
SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress response. Nature genetics (2023)
Shefali Thakur, Syed Haider, Rachael Natrajan
Implications of tumour heterogeneity on cancer evolution and therapy resistance: lessons from breast cancer. The Journal of pathology (2023)
Laura Gómez-Cuadrado, Esme Bullock, Zeanap Mabruk, Hong Zhao, Margarita Souleimanova, Pernille Rimmer Noer, Arran K Turnbull, Claus Oxvig, Nicholas Bertos, Adam Byron, J Michael Dixon, Morag Park, Syed Haider, Rachael Natrajan, Andrew H Sims, Valerie G Brunton
Characterisation of the Stromal Microenvironment in Lobular Breast Cancer. Cancers 14 (4) (2022)
Saira Khalique, Sarah Nash, Rachael Natrajan
Definitive study shows no association between ARID1A mutation status and clinical outcome in endometriosis-related ovarian cancers ‡ . The Journal of pathology 258 (1) (2022)
John Alexander, Odette Mariani, Celine Meaudre, Laetitia Fuhrmann, Hui Xiao, Kalnisha Naidoo, Andrea Gillespie, Ioannis Roxanis, Anne-Vincent Salomon, Syed Haider, Rachael Natrajan
Assessment of the Molecular Heterogeneity of E-Cadherin Expression in Invasive Lobular Breast Cancer. Cancers 14 (2) (2022)
Julia Stevenson, Rachel Barrow-McGee, Lu Yu, Angela Paul, David Mansfield, Julie Owen, Natalie Woodman, Rachael Natrajan, Syed Haider, Cheryl Gillett, Andrew Tutt, Sarah E Pinder, Jyoti Choudary, Kalnisha Naidoo
Proteomics of REPLICANT perfusate detects changes in the metastatic lymph node microenvironment. NPJ breast cancer 7 (1) (2021)
Ioanna Mavrommati, Flora Johnson, Gloria V Echeverria, Rachael Natrajan
Subclonal heterogeneity and evolution in breast cancer. NPJ breast cancer 7 (1) (2021)
Barrie Peck, Philip Bland, Ioanna Mavrommati, Gareth Muirhead, Hannah Cottom, Patty T Wai, Sarah L Maguire, Holly E Barker, Eamonn Morrison, Divya Kriplani, Lu Yu, Amy Gibson, Giulia Falgari, Keith Brennan, Gillian Farnie, Richard Buus, Rebecca Marlow, Daniela Novo, Eleanor Knight, Naomi Jayne Guppy, Daniela Kolarevic, Snezana Susnjar, Natasa Medic Milijic, Kalnisha Naidoo, Patrycja Gazinska, Ioannis Roxanis, Sunil Pancholi, Lesley-Ann Martin, Erle M Holgersen, Maggie Chon U Cheang, Farzana Noor, Sophie Postel-Vinay, Gerard Quinn, Simon S McDade, Lukas Krasny, Paul Huang, Frances Daley, Fredrik Wallberg, Jyoti S Choudhary, Syed Haider, Andrew N Tutt, Rachael Natrajan
3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer. Cancer research 81 (4) (2021)
Matthew Clarke, Alan Mackay, Britta Ismer, Jessica C Pickles, Ruth G Tatevossian, Scott Newman, Tejus A Bale, Iris Stoler, Elisa Izquierdo, Sara Temelso, Diana M Carvalho, Valeria Molinari, Anna Burford, Louise Howell, Alex Virasami, Amy R Fairchild, Aimee Avery, Jane Chalker, Mark Kristiansen, Kelly Haupfear, James D Dalton, Wilda Orisme, Ji Wen, Michael Hubank, Kathreena M Kurian, Catherine Rowe, Mellissa Maybury, Stephen Crosier, Jeffrey Knipstein, Ulrich Schüller, Uwe Kordes, David E Kram, Matija Snuderl, Leslie Bridges, Andrew J Martin, Lawrence J Doey, Safa Al-Sarraj, Christopher Chandler, Bassel Zebian, Claire Cairns, Rachael Natrajan, Jessica K R Boult, Simon P Robinson, Martin Sill, Ira J Dunkel, Stephen W Gilheeney, Marc K Rosenblum, Debbie Hughes, Paula Z Proszek, Tobey J Macdonald, Matthias Preusser, Christine Haberler, Irene Slavc, Roger Packer, Ho-Keung Ng, Shani Caspi, Mara Popović, Barbara Faganel Kotnik, Matthew D Wood, Lissa Baird, Monika Ashok Davare, David A Solomon, Thale Kristin Olsen, Petter Brandal, Michael Farrell, Jane B Cryan, Michael Capra, Michael Karremann, Cornelia Brendle, Martin Ulrich Schuhmann, Martin Ebinger, Winand N M Dinjens, Kornelius Kerl, Simone Hettmer, Torsten Pietsch, Felipe Andreiuolo, Pablo Hernáiz Driever, Andrey Korshunov, Lotte Hiddingh, Barbara C Worst, Dominik Sturm, Marc Zuckermann, Olaf Witt, Tabitha Bloom, Clare Mitchell, Evelina Miele, Giovanna Stefania Colafati, Francesca Diomedi-Camassei, Simon Bailey, Andrew S Moore, Timothy E G Hassall, Stephen P Lowis, Maria Tsoli, Mark J Cowley, David S Ziegler, Matthias A Karajannis, Kristian Aquilina, Darren R Hargrave, Fernando Carceller, Lynley V Marshall, Andreas von Deimling, Christof Maria Kramm, Stefan M Pfister, Felix Sahm, Suzanne J Baker, Angela Mastronuzzi, Andrea Carai, Maria Vinci, David Capper, Sergey Popov, David W Ellison, Thomas S Jacques, David T W Jones, Chris Jones
Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes. Cancer discovery 10 (7) (2020)
Saira Khalique, Stephen J Pettitt, Ger Kelly, Nina Tunariu, Rachael Natrajan, Susana Banerjee, Christopher J Lord
Longitudinal analysis of a secondary BRCA2 mutation using digital droplet PCR. The journal of pathology. Clinical research 6 (1) (2019)
Rachel Barrow-McGee, Julia Procter, Julie Owen, Natalie Woodman, Cristina Lombardelli, Ashutosh Kothari, Tibor Kovacs, Michael Douek, Simi George, Peter A Barry, Kelvin Ramsey, Amy Gibson, Richard Buus, Erle Holgersen, Rachael Natrajan, Syed Haider, Michael J Shattock, Cheryl Gillett, Andrew Nj Tutt, Sarah E Pinder, Kalnisha Naidoo
Real-time ex vivo perfusion of human lymph nodes invaded by cancer (REPLICANT): a feasibility study. The Journal of pathology 250 (3) (2019)
Saira Khalique, Kalnisha Naidoo, Ayoma D Attygalle, Divya Kriplani, Frances Daley, Anne Lowe, James Campbell, Thomas Jones, Michael Hubank, Kerry Fenwick, Nicholas Matthews, Alistair G Rust, Christopher J Lord, Susana Banerjee, Rachael Natrajan
Optimised ARID1A immunohistochemistry is an accurate predictor of ARID1A mutational status in gynaecological cancers. The journal of pathology. Clinical research 4 (3) (2018)

Rachael Natrajan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Rachael Natrajan